Clinical Trials on Organ Transplantation, Renal Transplantation

Total 10913 results

Novartis

Completed

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients (CERTES02)

Organ Transplantation, Renal Transplantation
University of Wisconsin, Madison

Completed

Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients

Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantion

United States
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate FK778 in Kidney Transplant Patients

Kidney Transplantation | Renal Transplantation | Transplantation, Kidney | Grafting, Kidney | Transplantation, Renal

Belgium, Germany, Spain, Sweden, Italy, Switzerland, United Kingdom, Austria, France, Poland, Czech Republic, Netherlands
National Institute of Allergy and Infectious Diseases...
PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)

Active, not recruiting

Tolerance by Engaging Antigen During Cellular Homeostasis (TEACH)

Kidney Transplantation | Renal Transplantation | Renal Transplant Recipient

United States
University of Oslo School of Pharmacy

Completed

Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation

Heart Transplantation | Renal Transplantation

Norway
Astellas Pharma Korea, Inc.

Completed

A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients (SINGLE)

Kidney Transplantation | Renal Transplantation | Stable Renal Recipients

Korea, Republic of
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation

Terminated

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

Kidney Transplantation | Renal Transplantation

United States
University of North Carolina, Chapel Hill
Mallinckrodt

Withdrawn

Acthar for Treatment of Post-transplant FSGS

Kidney Transplantation | Renal Transplantation | FSGS

United States
Bristol-Myers Squibb

Completed

Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney

Kidney Transplantation | Graft Rejection | Renal Transplantation

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Study of Tolerant Kidney Transplant Recipients (FACTOR)

Kidney Transplantation | Renal Transplant | Renal Transplantation | Transplant Rejection | Transplant Tolerance

United States
Rabin Medical Center

Recruiting

Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction

Renal Transplantation

Israel
Bristol-Myers Squibb

No longer available

A Belatacept Compassionate Use Study for Patients With a Kidney Transplant

Renal Transplantation

United States
California Pacific Medical Center Research Institute
Novartis Pharmaceuticals

Completed

Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic (MYFIIRP)

Renal Transplantation

United States
University Hospital, Tours
Laboratory of Biochemistry, University François Rabelais of TOURS

Completed

Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine (RENALIFE)

Renal Transplantation

France
Bristol-Myers Squibb

Completed

Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant (BENEFIT-EXT)

Renal Transplantation

United States, Argentina, Germany, Italy, Chile, Spain, Brazil, Sweden, Belgium, France, Hungary, Australia, South Africa, Austria, Canada, United Kingdom, Poland, Czechia, Norway
Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Terminated

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Renal Transplantation

Germany
Aurinia Pharmaceuticals Inc.

Withdrawn

Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation (INSPIRE)

Renal Transplantation
Bristol-Myers Squibb

Completed

Belatacept Pharmacokinetic Trial in Renal Transplantation

Renal Transplantation

Argentina, Mexico, United States
Astellas Pharma Inc

Completed

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Renal Transplantation

United States
Novartis Pharmaceuticals

Completed

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

Renal Transplantation
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals

Completed

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

Renal Transplantation

United States
Novartis

Completed

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Rapamune in Patients After Kidney Transplantation

Renal Transplantation

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

Renal Transplantation
University Hospital Schleswig-Holstein

Unknown

Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

Renal Transplantation

Germany
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients (EUTRAIN IMPACT)

Renal Transplantation

Spain, France, Germany, Switzerland
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Active, not recruiting

Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient. (APT'x)

Renal Transplantation

France
University of Cincinnati

Completed

Belatacept Early Steroid Withdrawal Trial

Renal Transplantation

United States
Helwan University
Ain Shams University

Completed

Effect of Genetic Polymorphism on Calcineurin Inhibitors Levels in Egyptian Renal Transplant Patients

Renal Transplantation

Egypt
Astellas Pharma S.A.S.

Completed

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) (OPALE)

Renal Transplantation

France
University of Wisconsin, Madison

Completed

A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation

Renal Transplantation

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Novartis

Completed

A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

Renal Transplantation

Switzerland
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Renal Transplantation
Pfizer

Completed

Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

Renal Transplantation

Argentina
Nantes University Hospital

Completed

A Study of Mycophenolate Mofetil and Cyclosporin, Without Concomitant Corticosteroids, After a First Renal Transplant

Renal Transplantation

France
University of Oslo School of Pharmacy

Terminated

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Renal Transplantation

Norway
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Renal Transplantation
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Renal Transplantation

France
Novartis

Completed

Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Renal Transplantation
Novartis

Completed

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Renal Transplantation
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University

Unknown

Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

Renal Transplantation

China
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

Optimizing Prograf® Therapy in Renal Transplant Patients (OPTIMA)

Renal Transplantation

United States

3

Subscribe